ID   K7M3
AC   CVCL_XG68
DR   Wikidata; Q94336003
RX   PubMed=17671136;
RX   PubMed=24136885;
CC   Characteristics: Established by intravenous injection of parent cell line into mice and then harvesting the lung metastases.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C24021; Mouse osteosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_V455 ! K7M2-WT
SX   Female
AG   895D
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 4
//
RX   PubMed=17671136; DOI=10.1158/1078-0432.CCR-07-0313; PMCID=PMC4503209;
RA   Gordon N., Koshkina N.V., Jia S.-F., Khanna C., Mendoza A., Worth L.L.,
RA   Kleinerman E.S.;
RT   "Corruption of the Fas pathway delays the pulmonary clearance of
RT   murine osteosarcoma cells, enhances their metastatic potential, and
RT   reduces the effect of aerosol gemcitabine.";
RL   Clin. Cancer Res. 13:4503-4510(2007).
//
RX   PubMed=24136885; DOI=10.1002/pbc.24801; PMCID=PMC4154381;
RA   Guma S.R., Lee D.A., Yu L., Gordon N., Hughes D., Stewart J.,
RA   Wang W.-L., Kleinerman E.S.;
RT   "Natural killer cell therapy and aerosol interleukin-2 for the
RT   treatment of osteosarcoma lung metastasis.";
RL   Pediatr. Blood Cancer 61:618-626(2014).
//